{"transactions":[{"id":744603,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T20:15:30.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":16000,"derivative":{"exercise_price":6.04,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001814892-26-000002","document":"form4-06092026_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000181489226000002/form4-06092026_040606.xml","form_type":"4"}},{"id":1117868,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:45:11.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-016287","document":"form4-06092025_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588925016287/form4-06092025_040601.xml","form_type":"4"}},{"id":1425180,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:12:00.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean August 20, 2024."}],"balance_after":50000,"derivative":{"exercise_price":0.344,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-022010","document":"form4-08222024_080856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924022010/form4-08222024_080856.xml","form_type":"4"}},{"id":1486751,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:15:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.78,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-015959","document":"form4-06072024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588924015959/form4-06072024_040609.xml","form_type":"4"}},{"id":1776113,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-20T21:49:59.000Z","date":"2023-09-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean September 19, 2023."}],"balance_after":25000,"derivative":{"exercise_price":0.8,"expiration_date":"2033-09-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-050191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123050191/doc4.xml","form_type":"4"}},{"id":1858773,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T13:03:59.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-23-036149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919123036149/doc4.xml","form_type":"4"}},{"id":2234166,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:17:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 9, 2022 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":2.15,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-22-036297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919122036297/doc4.xml","form_type":"4"}},{"id":2247324,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T21:09:59.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean June 1, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-033616","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122033616/doc4.xml","form_type":"4"}},{"id":2374542,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-24T22:02:42.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant.  \"Date of Grant\" shall mean February 23, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-02-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-012742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122012742/doc4.xml","form_type":"4"}},{"id":2663816,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:31:13.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":8109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."}],"balance_after":8109,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":8109},"source":{"system":"sec-edgar","filing":"0001209191-21-041443","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121041443/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-14"}},{"id":2670194,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:56:47.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-21-040265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121040265/doc4.xml","form_type":"4"}},{"id":2688800,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-01T23:33:08.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting.  \"Date of Grant\" shall mean May 28, 2021."}],"balance_after":20000,"derivative":{"exercise_price":35.54,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-021419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321021419/doc4.xml","form_type":"4"}},{"id":3071389,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-03T22:34:36.000Z","date":"2020-08-01","kind":"grant","acquired":true,"shares":17502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total shares subject to the option shall vest on August 1, 2021 and 1/36th of the total shares subject to the option shall\nvest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such\nvesting date."}],"balance_after":17502,"derivative":{"exercise_price":6.56,"expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":17502},"source":{"system":"sec-edgar","filing":"0001209191-20-044548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120044548/doc4.xml","form_type":"4"}},{"id":3106869,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":40055,"kind":"person","name":"Eichenfield Lawrence","position":1,"cik":"0001814892","reported_name":"Eichenfield Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T00:54:36.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the Date of Grant.  \"Date of Grant\" shall mean June 15, 2020."}],"balance_after":30000,"derivative":{"exercise_price":18.9,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-016935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924320016935/doc4.xml","form_type":"4"}}]}